Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Oosting

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
BMC Cancer|October 31, 2008
Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesisEsther H Lips, Ronald van Eijk, Eelco J R de Graaf, et al.
The British Journal of Surgery|February 18, 2022
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinomaArnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
BMC Cancer|May 7, 2010
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?Eddy H J van Roon, Marjo van Puijenbroek, Anneke Middeldorp, et al.
Cancer Immunology Research|January 12, 2017
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune SignatureSara M Melief, Valeria V Visconti, Marten Visser, et al.
The British Journal of Surgery|May 13, 2022
Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinomaArnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
Allergy|December 14, 2024
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE LevelsCoco Dekkers, Nicolaas Zuithoff, Daphne Bakker, et al.
The American Journal of Pathology|February 19, 2013
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targetsJolieke G van Oosterwijk, Danielle Meijer, Maayke A J H van Ruler, et al.
Oncotarget|April 21, 2015
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell linesJohnny Suijker, Jan Oosting, Annemarie Koornneef, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 12, 2026
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable MutationsMerve Kaya, Lawrence H Lin, Jan Oosting, et al.
Journal for Immunotherapy of Cancer|September 3, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapyElham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
BMC Cancer|October 31, 2008
Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesisEsther H Lips, Ronald van Eijk, Eelco J R de Graaf, et al.
The British Journal of Surgery|February 18, 2022
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinomaArnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
BMC Cancer|May 7, 2010
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?Eddy H J van Roon, Marjo van Puijenbroek, Anneke Middeldorp, et al.
Cancer Immunology Research|January 12, 2017
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune SignatureSara M Melief, Valeria V Visconti, Marten Visser, et al.
The British Journal of Surgery|May 13, 2022
Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinomaArnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
Allergy|December 14, 2024
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE LevelsCoco Dekkers, Nicolaas Zuithoff, Daphne Bakker, et al.
The American Journal of Pathology|February 19, 2013
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targetsJolieke G van Oosterwijk, Danielle Meijer, Maayke A J H van Ruler, et al.
Oncotarget|April 21, 2015
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell linesJohnny Suijker, Jan Oosting, Annemarie Koornneef, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 12, 2026
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable MutationsMerve Kaya, Lawrence H Lin, Jan Oosting, et al.
Journal for Immunotherapy of Cancer|September 3, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapyElham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman, et al.
Pageof 7